Raveen Rathnasinghe - Concepedia

Author

Raveen Rathnasinghe

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Rathnasinghe, Raveen, Raveen Rathnasinghe

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Tisch Hospital Texas Biomedical Research Institute Quantitative BioSciences Gladstone Institutes

About

Raveen Rathnasinghe is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.8K
2	Public Health	2	2	140
3	Epidemiology	2	2	140
4	Allergy	1	1	20
5	Cell Biology	1	1	356

Raveen Rathnasinghe

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing Laura Riva, Shuofeng Yuan, Xin Yin, Nature Large-scale Compound RepurposingMedicineAntiviral Drug DevelopmentVirologyAntiviral Drug	2020	837
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling Lisa Miorin, Thomas Kehrer, María Teresa Sánchez-Aparicio, Proceedings of the National Academy of Sciences	2020	550
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A Kris M. White, Romel Rosales, Soner Yildiz, Science MedicineViral PathogenesisImmunologyAntiviral ResponseVirology	2021	356
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2 Tia A. Tummino, Veronica V. Rezelj, Benoit Fischer, Science Medicinal ChemistryAntiviral ActivityMedicineImmunologyEarly Drug Discovery	2021	218
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection Raveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat, Emerging Microbes & Infections	2020	203
Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission Alba Escalera, Ana S. Gonzalez‐Reiche, Sadaf Aslam, Cell Host & Microbe Concern LinkSars-cov-2 VariantsSpike CleavageViral PathogenesisImmunology	2022	194
The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera Sonia Jangra, Chengjin Ye, Raveen Rathnasinghe,	2021	145
The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera Raveen Rathnasinghe, Sonia Jangra, Anastasija Čupić,	2021	136
Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection Drishti Kaul, Raveen Rathnasinghe, Marcela Ferrés, Nature Communications Microbiome HomeostasisDysbiosisMicrobial PathogensUpper Respiratory TractViral Dynamic	2020	122
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation Jessica Ho, Bobo Wing-Yee Mok, Laura Campisi, Cell Top1 Inhibition TherapyImmunologyAntiviral ResponseAntiviral Drug Development	2021	120

Page 1